Skip to Content

Aminocaproic Acid

In the US, Aminocaproic Acid (aminocaproic acid systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Fibrinolytic Bleeding.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Hemostatic agent: Antifibrinolytic

Chemical Name

6-Aminohexanoic acid (WHO)

Foreign Names

  • Acidum Aminocaproicum (Latin)
  • Aminocapronsäure (German)
  • Acide aminocaproïque (French)
  • Ácido aminocapróico (Spanish)

Generic Names

  • ε-Aminocaproic Acid (OS: JAN)
  • Acide aminocaproïque (OS: DCF)
  • Aminocaproic Acid (OS: BAN, USAN)
  • CL 10304 (IS)
  • CY 116 (IS)
  • Eaca (IS)
  • JD 177 (IS)
  • Acidum aminocaproicum (PH: Ph. Eur. 8)
  • Aminocaproic Acid (PH: BP 2016, USP 38)
  • Aminocaproic acid (PH: Ph. Eur. 8)
  • Aminocaproique (acide) (PH: Ph. Eur. 8)
  • Aminocapronsäure (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.